Patents by Inventor Gerard Marriott

Gerard Marriott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10794915
    Abstract: Isolated truncated and mutated sensor proteins derived from flavoproteins that are 12-20 KDa or less, genetically encoded for detection and imaging of protein complexes having long fluorescent lifetimes that can be 4.0 ns or greater.
    Type: Grant
    Filed: November 19, 2015
    Date of Patent: October 6, 2020
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, PRESIDENT AND BOARD OF TRUSTEES OF SANTA CLARA COLLEGE
    Inventors: Gerard Marriott, Alexander Chris Hoepker, Yuling Yan
  • Publication number: 20160166185
    Abstract: Provided is a blood analyte collection device that includes a microneedle array configured to provide fluid communication between a cellular interstitial fluid of a subject and a collection device fluid, a device chamber containing the collection device fluid, and a sequestration material in the device chamber configured to bind to a blood analyte from the cellular interstitial fluid. Also provided are methods and kits that use the subject blood analyte collection device. The subject devices, methods and kits find use in a variety of applications, such as detecting a blood analyte, such as glucose, in a subject.
    Type: Application
    Filed: August 21, 2014
    Publication date: June 16, 2016
    Inventors: Dorian Liepmann, Jacobo Paredes, Gerard Marriott
  • Publication number: 20160146827
    Abstract: Isolated truncated and mutated sensor proteins derived from flavoproteins that are 12-20 KDa or less, genetically encoded for detection and imaging of protein complexes having long fluorescent lifetimes that can be 4.0 ns or greater.
    Type: Application
    Filed: November 19, 2015
    Publication date: May 26, 2016
    Inventors: Gerard Marriott, Alexander Chris Hoepker, Yuling Yan
  • Patent number: 7301020
    Abstract: Macrolide analogs and methods for identifying macrolide analogs capable of unregulated inhibition of actin filament dynamics are provided. A method according to the invention includes the steps of: (a) contacting F-actin with a candidate compound; and (b) assaying the candidate compound's ability to sever the F-actin and cap resulting F-actin (+)-ends. The candidate compound is identified as a macrolide analog where said candidate compound displays an ability to sever F-actin and, following severing, the resulting F-actin (+)-end is capped by the candidate compound thusly preventing subsequent G-actin incorporation. Severing and capping activities are unregulated; i.e., independent of at least physiologically-meaningful concentrations of phosphatidyl inositol and calcium.
    Type: Grant
    Filed: June 16, 2004
    Date of Patent: November 27, 2007
    Assignee: Wisconsin Alumni Research Foundation
    Inventor: Gerard Marriott
  • Publication number: 20070195309
    Abstract: The present invention provides photochromic compounds and derivatives thereof as shown in claim 1 and methods of use of these compounds and derivatives. The present invention also provides photochromic optical probes capable of undergoing light directed reversible transition between a first state and a second state. The invention also teaches methods of determining and controlling reversible optical biomolecular interactions, for example binding of calcium in a subject.
    Type: Application
    Filed: November 18, 2005
    Publication date: August 23, 2007
    Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Gerard MARRIOTT, Tomoyo SAKATA, Yuling YAN
  • Publication number: 20040259185
    Abstract: Macrolide analogs and methods for identifying macrolide analogs capable of unregulated inhibition of actin filament dynamics are provided. A method according to the invention includes the steps of: (a) contacting F-actin with a candidate compound; and (b) assaying the candidate compound's ability to sever the F-actin and cap resulting F-actin (+)-ends. The candidate compound is identified as a macrolide analog where said candidate compound displays an ability to sever F-actin and, following severing, the resulting F-actin (+)-end is capped by the candidate compound thusly preventing subsequent G-actin incorporation. Severing and capping activities are unregulated; i.e., independent of at least physiologically-meaningful concentrations of phosphatidyl inositol and calcium.
    Type: Application
    Filed: June 16, 2004
    Publication date: December 23, 2004
    Inventor: Gerard Marriott